Loading the security overview…
Where the tokens are
Trade PTNFirst the companies classified under the same themes, most themes in common first; then the ones investors most often look at alongside PTN. A peer with a tokenized version links to its own page, where every issuer that wraps it is listed.
| Company | Shared themes | Market cap | P/E | P/S | EV/EBITDA | ROE | F-Score | Altman zone |
|---|---|---|---|---|---|---|---|---|
 PTNThis companyPalatin Technologies, Inc. Common Stock | — | $16.14M | — | 1.2 | -1.0 | −125.3% | 2/9 | distress |
 AMGNTokenizedAmgen Inc | Rare Disease Therapeutics | $220.18B | 25.2 | 5.8 | 16.4 | 74.8% | 7/9 | safe |
 VRTXTokenizedVertex Pharmaceuticals Inc | Rare Disease Therapeutics | $128.44B | 29.2 | 10.2 | 23.8 | 21.8% | 5/9 | safe |
 ARGXargenx SE American Depositary Shares | Rare Disease Therapeutics | $66.02B | — | — | — | — | — | — |
 ALNYTokenizedAlnylam Pharmaceuticals, Inc. | Rare Disease Therapeutics | $30.93B | 38.3 | 6.4 | 28.7 | 59.7% | 6/9 | safe |
 UTHRTokenizedUnited Therapeutics Corp | Rare Disease Therapeutics | $24.51B | 18.7 | 7.8 | 15.2 | 20.5% | 7/9 | safe |
 INCYTokenizedIncyte Genomics Inc | Rare Disease Therapeutics | $23.74B | 14.7 | 4.1 | 10.2 | 25.4% | 8/9 | safe |
 INSMTokenizedInsmed, Inc. | Rare Disease Therapeutics | $23.71B | — | 20.9 | -28.9 | −115.5% | 4/9 | safe |
 BBIOTokenizedBridgeBio Pharma, Inc. Common Stock | Rare Disease Therapeutics | $13.08B | — | 18.3 | -31.5 | 27.5% | 2/9 | distress |
 CORTTokenizedCorcept Therapeutics Inc. | Rare Disease Therapeutics | $12.33B | 226.2 | 14.8 | 1446.6 | 7.7% | 5/9 | safe |
 BMRNTokenizedBioMarin Pharmaceuticals Inc | Rare Disease Therapeutics | $11.31B | 155.0 | 3.3 | 47.9 | 1.1% | 5/9 | safe |
 KRYSKrystal Biotech, Inc. Common Stock | Rare Disease Therapeutics | $9.63B | 39.9 | 21.9 | 45.2 | 17.8% | 6/9 | safe |
 ARWRTokenizedArrowhead Research Corporation | Rare Disease Therapeutics | $9.15B | — | 13.7 | -49.6 | −68.7% | 6/9 | safe |
 CYTKCytokinetics Inc. | Rare Disease Therapeutics | $9.12B | — | 134.8 | -14.4 | 515.3% | 2/9 | distress |
 CRNXCrinetics Pharmaceuticals, Inc. | Rare Disease Therapeutics | $9.01B | — | 213.8 | -16.4 | −42.1% | 2/9 | safe |
Figures describe Palatin Technologies, Inc. - Backpack Securities shares, not any token. From theme classifications, Massive's related companies and the latest ratios and scores. Ratios are trailing, each as of its own latest filing. Peers are for comparison, not a list of alternatives to buy.